Cloetta (OM:CLA B) After Strong Q2 Results Looks Close To Fair Value

Cloetta (OM:CLA B) stock is in focus after the company reported Q2 2026 earnings with higher net income, improved earnings per share, and an operating margin above its long term target, supported by volume driven organic growth.

See our latest analysis for Cloetta.

The latest Q2 report appears to have reinforced already strong momentum in Cloetta, with the share price at SEK56.75 and a 30 day share price return of 15.58%. The 1 year total shareholder return of 82.77% and 3 year total shareholder return above 200% point to a strong longer term rerating that investors are reassessing against current earnings quality and risk.

If Cloetta’s recent move has you thinking about where else momentum and quality might intersect, it could be a useful moment to look at 107 top founder-led companies

After Cloetta’s rapid rerating, supported by higher earnings and a strong balance sheet, the key issue now is simple: does the current valuation still leave enough upside to justify fresh risk for new buyers?

Most Popular Narrative: 3.8% Undervalued

Cloetta’s most followed valuation narrative points to a fair value of SEK59 per share, slightly above the last close at SEK56.75. This keeps the current rally in context rather than dismissing it.

The analysts have a consensus price target of SEK59.0 for Cloetta based on their expectations of its future earnings growth, profit margins and other risk factors.

In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be SEK9.6 billion, earnings will come to SEK904.7 million, and it would be trading on a PE ratio of 21.2x, assuming you use a discount rate of 5.3%.

Read the complete narrative.

Want to see what sits behind that fair value for Cloetta? The narrative refers to steady top line expansion, firmer margins and a richer earnings multiple. Curious which exact profit and revenue paths have been plugged in, and how they combine into that discounted value over several years? The full narrative lays out the blueprint.

Result: Fair Value of SEK59 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Cloetta’s story could change if new product formats fail to keep consumer interest, or if expansion into markets like Germany and North America disappoints.

Find out about the key risks to this Cloetta narrative.

Another View: Cloetta Through the P/E Lens

The DCF workup points to Cloetta trading at a discount, yet the P/E ratio tells a different story. At 19.2x earnings versus 16.3x for the European Food sector and a fair ratio of 18.3x, the stock appears richer rather than cheaper. This raises the question of which signal may be more relevant for you.

This tension between discounted cash flow and earnings multiples highlights the value of examining how the P/E gap and fair ratio have been assessed in detail, and what this could indicate about potential valuation risk or opportunity over time, in the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Sentiment on Cloetta is mixed, with both risks and rewards in play. Consider reviewing the data for yourself and weighing up the trade offs by checking the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Cloetta?

If Cloetta has sharpened your focus on quality and momentum, do not stop here. Use the Simply Wall Street Screener to uncover fresh ideas that fit your style.

• Target steadier potential returns by checking resilient stocks with 293 resilient stocks with low risk scores that may help balance out more aggressive positions.
• Hunt for quality at a reasonable price by reviewing companies in the 234 high quality undervalued stocks that pair solid fundamentals with attractive valuations.
• Strengthen your income stream by reviewing businesses in the 457 dividend fortresses that combine higher yields with a focus on stability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com